Rhonda Farnum sold $227k of TBPH
SVP, COMM & MEDICAL AFFAIRS at Theravance Biopharma, Inc.. 13,314 shares at an average of $17.03, traded Sep 15, 2026, filed Sep 17, 2026.
Score components
- +15RoleOfficer
- +13Trade size$227k at market
- 0Share of holdings soldSold 5.9% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001898490-26-000014, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | SOpen-market sale Ordinary Shares10b5-1 | -3,329 | $17.03 | $57k | 223,461 | 25 d ago |
| Sep 15, 2026 | SOpen-market sale Ordinary Shares10b5-1 | -3,328 | $17.03 | $57k | 220,133 | 25 d ago |
| Sep 15, 2026 | SOpen-market sale Ordinary Shares10b5-1 | -6,657 | $17.03 | $113k | 213,476 | 25 d ago |
Related signals
Other insiders at Theravance Biopharma, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | Theravance Biopharma, Inc. | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | $264k 24,000 shares | -7% | |
| 1Weak | Theravance Biopharma, Inc. | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | $36k 4,000 shares | -1% | |
| 1Weak | Theravance Biopharma, Inc. | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | $36k 4,000 shares | -1% | |
| 21Weak | TBPHsell Theravance Biopharma, Inc. | Rhonda Farnum SVP, COMM & MEDICAL AFFAIRS | $36k 4,000 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.